Latest prostate cancer News | Page 7

Postcard from Geelong: Meet Bill Rebula
Q&A with Bill Rebula Geelong Prostate Cancer Support Group Convenor
In Memory of Emeritus Professor Pamela Russell AM
24-hr Gippsland pedal to power prostate cancer research
Prostate Health Index Density
Lynparza plus abiraterone reduced risk of disease progression by 34% vs. standard-of-care in 1st-line metastatic
Applied Molecular Therapies launches its first theranostic product in prostate cancer treatment
Pancare Foundation launches initiatives to help people diagnosed with rare biliary cancer
Generous community donates more than $400,000 for WA cancer research
Forget-him-not this Valentine’s Day
One year of telenursing
10 years on: Reflections from survivor
Advanced prostate cancer antibody drug shows success in pet dogs
COVID breath test among 24 innovative projects backed to commercialise
New blood test combined with image-based prostate cancer screening reduces harms and costs
First patient dosed in Telix ‘ProstACT’ therapeutic program
Male carriers of BRCA1 and BRCA2 gene mutation also at risk of multiple cancers: study
Leading Queensland cancer specialist recognised in Australia Day honours
Significant capital raise for emerging Australian company
How data can help prevent overdiagnosis
Artificial intelligence equal to diagnosing prostate cancer, study finds
Large international evaluation shows AI accurately diagnoses prostate cancer
AstraZeneca aims to redefine liver, biliary tract and prostate cancer treatment with practice-changing Imfinzi and Lynparza data
New Year A-Team fundraising challenge set to be lifesaver
Four-wheel drive fundraiser revs up support for prostate cancer
MAPK4, novel therapeutic target for triple-negative breast cancer
Support for men with prostate cancer impacted by pandemic
Prostate cancer in Australia – what do numbers tell us?
Portable prostate cancer test may help reach underserved men
Medicine agency recommends listing of life-saving drugs for Australian men with deadly forms of prostate cancer
Revolutionary 3D imaging maps how breast cancer spreads
Simple solutions for stress-free Christmas
Cancer survival rates are improving in Australia
Active surveillance: where are we now?
Cancer survival rates continue to improve, while death and incidence rates fall
Lynparza granted Priority Review in US for BRCA-mutated HER2-negative high-risk early breast cancer
Changing face of men’s health
Bold vision to double prostate cancer funding and wipe out deaths from disease by 2040
New centre provides local care and makes Dubbo more attractive for doctors
Telix Pharmaceuticals says first Australian patient doses in global study
Monash receives $41m in NHMRC Ideas Grants
Prostate cancer support group launched in Meekatharra
Lutetium for metastatic castrate resistant prostate cancer
TGA approves Telix Pharmaceuticals’ Illuccix for prostate cancer
$15 million for innovative health and medical research
New support for prostate cancer patients
Coles joins Movember movement to raise funds for men’s health
Additional support for Australian men battling prostate cancer